Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • Log out
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Use of a Novel Real-Time Quantitative Reverse Transcription-Polymerase Chain Reaction Method to Study the Effects of Cytokines on Cytochrome P450 mRNA Expression in Mouse Liver

Jinmei Pan, Qian Xiang and Simon Ball
Drug Metabolism and Disposition June 2000, 28 (6) 709-713;
Jinmei Pan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qian Xiang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Ball
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

In this study, we developed a real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) method to study cytochrome P450 (CYP) mRNA regulation by cytokines in mouse liver. The method combines standard RT-PCR with a fluorogenic probe in which the intensity of fluorescence is proportional to the amount of target template present. We show that this method provides very rapid, sensitive, and reproducible quantification of mouse CypmRNA with a wide dynamic range of starting target molecule. We validated the method by using several prototypic CYP inducers. As expected, the mRNA levels of Cyp3a11,Cyp2b10, and Cyp1a2 were induced by a single dose of dexamethasone (100 mg/kg), phenobarbital (80 mg/kg), and 3-methylcholanthrene (80 mg/kg), respectively. The method of real-time RT-PCR was then used to evaluate the effects of interleukin (IL)-6 (100 ng/mouse), IL-1β (500 ng/mouse), and tumor necrosis factor (TNF)-α (2 μg/mouse) on Cyp mRNA expression in the mouse. Constitutive Cyp2b10 mRNA was reduced to 40% by IL-6 and 15% by IL-1β, whereas Cyp2d9 mRNA was reduced to 70% by TNF-α administration. The level of Cyp1a2 mRNA was suppressed to 67% by IL-6 and 59% by TNF-α.Cyp3a11 and Cyp2e1 mRNAs were not affected by any of the cytokines that were studied. We conclude that the real-time RT-PCR method is a powerful new tool to study CYP mRNA expression and regulation. Using this method, we are the first to report that the expression of constitutive Cyp2b10, 1a2, and 2d9 mRNAs was suppressed by proinflammatory cytokines.

Cytochrome P450 (CYP)1 enzymes play a critical role in the oxidative metabolism of a variety of endogenous and exogenous compounds, including most drugs. The expression of CYP genes is affected by physiological, genetic, and environmental factors. Among them, it has been shown that the expression of CYP can be markedly modulated by the factors or agents that activate the immune system, such as viral or bacterial infections (Renton and Knickle, 1990), immunization (Renton and Knickle, 1990), endotoxin (Shedlofsky et al., 1994), TNF-α (Nadin et al., 1995), and interferon inducers (Morgan and Norman, 1990). Studies in vitro and in vivo have demonstrated that the release of endogenous cytokines is responsible for the modulation (Ghezzi et al., 1986; Barker et al., 1992; Chen et al., 1992; Abdel-Razzak et al., 1993; Fukuda and Sassa, 1994; Morgan et al., 1994; Shedlofsky et al., 1994; Cantoni et al., 1995). The effects of cytokines released during inflammation on drug metabolism are of clinical interest. Although the mouse has been widely used as an animal model to evaluate the pharmacological and toxicological effects of cytokines during their development as therapeutic agents, the effects of cytokines on the CYP system in this species have not been fully studied. A major objective of the current study was to determine the effects of several proinflammatory cytokines (IL-6, IL-1β, and TNF-α) on mRNA expression of the majorCyp enzymes (Cyp3a11, 2b10, 2d9, 2e1, and 1a2) in mouse liver.

A number of methods are widely used to study the mRNA expression, which include Northern blot or slot-blot hybridization, RNase protection, and reverse transcription-polymerase chain reaction (RT-PCR). These common methods typically require relatively large amounts of total RNA (e.g., up to 10 μg) and are not suitable for high throughput. More importantly, they are typically semiquantitative in nature. Recently, a real-time quantitative RT-PCR method (TaqMan; ABI 7700) was developed that can overcome these limitations (Gibson et al., 1996; Heid et al., 1996). In this method, a probe is designed that hybridizes with the target sequence between forward and reverse primers (Bassler et al., 1995). The probe is labeled with a fluorescent reporter dye (6-carboxy-fluorescein) at the 5′ end and a quencher dye (6-carboxy-tetramethyl-rhodamine) at the 3′ end (Lee et al., 1993). When the probe is intact, fluorescence is quenched due to its proximity to the quencher dye. During each extension cycle, Taq DNA polymerase cleaves the reporter dye from the probe, which results in its separation from the quencher dye and emission of fluorescence from the reporter dye, which is a measure of the amount of target mRNA in the sample (Fig. 1; Livak et al., 1995). Unlike end point methods (i.e., band densitometry), real-time PCR is capable of monitoring amplification by increased probe fluorescence during the course of the each PCR cycle. In the present study, we demonstrated the use of real-time RT-PCR assay with several prototypic CYP inducers and applied this advanced technology to study the effects of cytokines on Cyp mRNA expression in mouse liver.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Amplification plot of Cyp3a11 mRNA.

A, total RNA input ranging from 0.3, 1, 3, 10, and 30 to 100 ng for Cyp3a11 was plotted by change in normalized reporter signal (ΔRn) versus cycle number. The curves represent the highest to lowest input RNA from left to right. Four replicates for each point were performed with no template control and no amplification control shown at baseline through 40 cycles (horizontal line). B, the standard curve of mouse Cyp3a11 mRNA was derived from amplification by plotting Ct versus log nanograms of total RNA input, which shows the linearity of a large dynamic range of the starting template amount. The Ct values decrease with increasing total RNA input.

Experimental Procedures

Materials.

Murine interleukin (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α were purchased from BioSource International (Camarillo, CA). Sodium phenobarbital (PB) was obtained from the Wyeth-Ayerst Research compound room (Princeton, NJ). Dexamethasone (DEX) and 3-methylcholanthrene (3-MC) were obtained from Sigma Chemical Co. (St. Louis, MO). TRIzol reagents, oligonucleotide primers (through custom synthesis), Superscript II, and RNase inhibitor were purchased from Life Technologies (Rockville, MD). TaqMan PCR Core Reagent Kit, TaqMan ribosomal RNA control reagent kit, and the oligonucleotide probes (custom synthesis) were purchased from PE Biosystems (Foster City, CA).

Methods.

Animal treatment

Male CD1 mice (8–10 weeks old; ∼30 g) were obtained from Charles River Laboratories (Raleigh, NC). Animals were allowed free access to food and water and were subjected to a 12-h light/dark cycle for 1 week before the experiment. Animals (five per group) received a single i.p. injection (0.3 ml) of IL-6 (100 ng/mouse), IL-1β (500 ng/mouse), TNF-α (2 μg/mouse), PB (80 mg/kg), 3-MC (80 mg/kg), or DEX (100 mg/kg; Kiyohara et al., 1990; Chen et al., 1992; Corcos, 1992). The vehicle control animals received 0.9% NaCl/0.1% BSA, or corn oil (for 3-MC). Animals were sacrificed 24 h after the treatment. Livers were excised and immediately frozen on dry ice and stored at −80°C before total RNA preparation.

RNA preparation.

Frozen livers were thawed on ice, and total RNA was isolated using TRIzol reagent. The quality of the isolated RNA was assessed by electrophoresis on 1% agarose gels based on the integrity of 28S and 18S bands after ethidium bromide staining.

Design of primers and probes.

The cDNA sequences of Cyp3a11, 2b10, 2d9, 2e1, and 1a2 were obtained from GenBank (accession numbers X60452, M21856, M27168,L11650, and X00479, respectively). PCR primers and fluorescent probe sequences were designed using PrimerExpress software (PE Biosystems) and shown in Table 1. The specificity ofCyp primers and probes was confirmed through alignment within the Cyp subfamily and by sequencing each RT-PCR amplicon. To avoid amplification of contaminating genomic DNA, one of the primers or the probe was placed at the junction between two exons. For example, Cyp1a2 forward primer crosses the junction of exons 3 and 4, whereas Cyp2d9 forward primer is from exon 5, and the probe and reverse primer are from exon 6.

View this table:
  • View inline
  • View popup
Table 1

Primer and probe sequences of mouse Cyp mRNA

Real-time RT-PCR.

RT and PCR were conducted in one step using TaqMan PCR Core Reagent Kit in a TaqMan 7700 Sequence Detector (PE Applied Biosystems) according to the manufacturer's protocol with slight modifications. Briefly, Master Mix solution was prepared at a final concentration of 5.5 mM MgCl2; 0.025 U/μl Taq DNA polymerase (Amplitaq Gold; PE Applied Biosystems); 0.15 U/μl Superscript II; 1× reaction buffer (PE Biosystems) containing 500 mM KCl, 100 mM Tris-HCl (pH 8), 0.1 M EDTA, and 600 nM passive reference 1; 0.3 mM concentration each of dATP, dGTP, and dCTP; 0.6 mM dUTP; and 0.1 U/μl RNase inhibitor. The primers and fluorescent probes were used at a final concentration of 200 and 100 nM, respectively. Probes used 6-carboxy-fluorescein as the reporter dye and 6-carboxy-tetramethyl-rhodamine as the quencher dye at the 5′ and 3′ ends, respectively. The reaction also contained the primers and probe of 18S rRNA, as a housekeeping gene, for normalization of target mRNA results. The quantitative RT-PCR for target template and 18S rRNA was run in the same plate but separate tubes. RT reaction mixtures were preincubated at 60°C for 30 min and then at 95°C for 5 min to activate AmpliTaq Gold DNA polymerase. Two-step thermocycling was performed for 40 cycles: denaturation at 95°C for 20 s and anneal/extension at 58–60°C for 1 min. Increases in fluorescence, which were due to the cleavage of the reporter dye as the PCR proceeded relative to the starting values of delta normalized reporter fluorescence (ΔRn), were determined and plotted by the instrument against cycle number (Fig. 1). Ct values (the PCR cycle number required for fluorescence intensity to exceed an arbitrary threshold in the exponential phase of the amplification) were then determined for a series of standards. A standard curve was generated by plotting Ct versus the log of the amount of total RNA added to the reaction (0.3–100 ng; Bulletin 2, PE Applied Biosystems) and used to compare the relative amount of a particular Cyp mRNA in the samples from control and cytokine-treated animals. Calculations of Ct and ΔRn, standard curve preparation, and quantification of mRNA in the samples were performed by the software provided with the ABI 7700 system (Heid et al., 1996).

Results

Development of Real-Time RT-PCR Assay.

Standard curve and reproducibility

Figure 1A shows a representative amplification plot for Cyp3a11 that was established by plotting the ΔRn versus PCR cycle number. There was no increase in fluorescence in the control samples either without the template or without the reverse transcriptase, indicating the absence of DNA contamination in the system and the samples (Fig.1A). The resulting standard curve of Ct against log nanograms of total RNA input was highly linear, as shown by a correlation coefficient (R2) value of >0.99 over a wide range of total RNA input (0.3–100 ng; Fig. 1B). Similar amplification plots and standard curves were obtained for Cyp2b10, 2d9, 2e1, and 1a2 (data not shown).

In addition, the method was highly reproducible, as demonstrated by the small standard deviation (0.03–0.16) and coefficient of variation (<1) of quadruplicate determinations in Table2 (1 and 100 ng of total RNA input).

View this table:
  • View inline
  • View popup
Table 2

Reproducibility of Ct versus input total RNA

Method validation with classic Cyp inducers.

The real-time RT-PCR method that had been developed forCyp3a11, 2b10, 2d9, 2e1, and 1a2 was further validated by measuring mRNA expression in livers of the mice treated with classic inducers (PB, 3-MC, and DEX), and the results were compared with those for control (uninduced) animals (Fig. 2). PB induced Cyp3a11, 2b10, and 1a2 mRNA by 4-, 22-, and 3-fold, respectively. 3-MC potently induced Cyp1a2 mRNA by 17-fold, whereas DEX induced both Cyp3a11 and 2d9 mRNA by 5-fold. Cyp2e1 mRNA was moderately, but significantly, suppressed (∼30%) by PB but unaffected by DEX or 3-MC. The result of Western blot analysis using rat CYP2B1/2, CYP2E1, and CYP3A2 antibodies, respectively, showed that Cyp2b-like andCyp3a-like proteins were dramatically induced by PB treatment, whereas Cyp2e1 protein was suppressed by 50% (data not shown).

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

Effect of classic inducers on expression of Cyp mRNA assayed by real-time RT-PCR.

CD1 mice were injected once i.p. for 24 h with PB, 3-MC, and DEX, respectively. Control mice were injected with 0.9% NaCl/0.1% BSA, or corn oil only. Total RNA (10 ng) was loaded for one-step RT-PCR real-time assay of Cyp3a11, 2b10, 2d9, 2e1, and 1a2 mRNAs.

Modulation of Mouse Cyp mRNA by Cytokines.

After establishing the real-time RT-PCR method, it was subsequently used to study the effect of proinflammatory cytokines on CypmRNA expression in the mouse. IL-1β and IL-6 significantly suppressed the expression of constitutive Cyp2b10 mRNA to 40 and 15% of control values, respectively (Table3). IL-6 also suppressedCyp1a2 mRNA levels by 67%. These cytokines had little or no effect on the expression of the other mouse Cyp mRNAs that were studied (Cyp3a11, 2d9, and 2e1). TNF-α decreasedCyp1a2 mRNA by 59% and also significantly suppressedCyp2d9 mRNA to 70% of control values. TNF-α did not affect Cyp3a11, 2b10, and 2e1 mRNA levels.

View this table:
  • View inline
  • View popup
Table 3

Effect of cytokines on mouse Cyp mRNA levels

Discussion

To our knowledge, this is the first application of real-time RT-PCR TaqMan method to study CYP mRNA expression. In the present study, we demonstrated that this method is highly reproducible, as demonstrated by low coefficients of variation as well as day-to-day reproducibility (data not shown). This method also works over an extended dynamic range (0.3–100 ng of total RNA input). In addition, the TaqMan method is exquisitely sensitive (0.3 ng of total RNA input or less) and quantitative. This is in contrast to existing methodologies that often require micrograms of total RNA (e.g., Northern blot, slot-blot, and RNase protection assays). This methodology could be therefore particularly useful in studies where the amount of target mRNA may be very low; such as in extrahepatic tissues or in cultured cells. In addition, the method does not require electrophoretic gels to be run, and the assay can be performed in a high throughput format, such as a 96-well microtiter plate. Furthermore, this method contains fluorescence probe as well as the use of gene-specific PCR primers, which provides additional specificity in gene superfamilies, because a positive fluorescent signal can be generated from a PCR product only if both the primers and the probe hybridize to the template cDNA.

We have confirmed the suitability of using the real-time RT-PCR method to study Cyp mRNA expression with several prototypic CYP inducers. As expected, we found that PB induced Cyp2b10 and 3a11 mRNA expression, as well as the levels of Cyp2b-like and 3a-like protein (data not shown), which is consistent with the literature (Corcos, 1992; Damon et al., 1996). We also demonstrated that PB appeared to induce Cyp1a2 mRNA expression (∼3-fold) in this strain of mouse (CD1). This observation is interesting because arylhydrocarbons (e.g., 3-MC), not PB, are generally considered to induce the CYP1A gene family. This finding is consistent with Sakuma et al. (1999), who recently demonstrated thatCyp1a2 mRNA is induced by PB and other barbiturates in aryl hydrocarbon-responsive (C57BL/6, C3H) and nonresponsive (DBA/2, AKR, NZB) mice. It was also interesting to find that PB markedly suppressedCyp2e1 mRNA. Suppression of mRNA encoding this enzyme has been observed in the Western blot analysis by using anti-rat CYP2E1 antibody. The finding that DEX markedly induced Cyp2d9 (∼5-fold) was also a new and intriguing finding in that this gene subfamily is generally considered to be refractory to induction. The magnitude of this effect (∼5-fold) was comparable with the expected effects of this agent (Corcos, 1992) on Cyp3a11 mRNA levels and suggests common or overlapping regulatory mechanisms for these two enzymes in this species.

The new quantitative RT-PCR technique was then used to study the effects of several proinflammatory cytokines on the expression of specific mouse Cyp mRNAs. Consistent with reported effects of these compounds on CYP expression in a number of other species (Chen et al., 1995; Monshouwer et al., 1996), including humans (Abdel-Razzak et al., 1993; Fukuda and Sassa, 1994), all three proinflammatory cytokines were found to down-regulate mouse Cyp mRNA. However, these effects were highly cytokine/isoenzyme-selective. For example, IL-6 and IL-1β suppressed Cyp2b10 mRNA without affecting the enzymes of Cyp3a11, 2e1, and 2d9. Although both of these cytokines are known to decrease CYP2B induction in response to PB (Clark et al., 1995), this is the first time that these cytokines have been shown to reduce constitutive expression of this gene subfamily. Similar cytokine/isoenzyme-specific effects have been noted in other species. For example, IL-6 down-regulates CYP2C11, but not CYP3A2, mRNA in the rat (Chen et al., 1995). This selectivity is important from both a clinical and toxicological perspective and because it implies that effects on CYP mRNA may occur via multiple mechanisms.

The finding that TNF-α suppressed Cyp1a2 mRNA levels was consistent with the noted down-regulation of Cyp1a activity and mRNA by this cytokine in cultured murine hepatoma cells (Paton and Renton, 1998). IL-6, as well as TNF-α, also markedly decreasedCyp1a2 mRNA in the present study. It is noteworthy that both TNF-α and IL-6 suppress CYP1A2 expression in cultured human hepatocytes (Abdel-Razzak et al., 1993; Guillen et al., 1998). Our finding that Cyp2d9 mRNA was down-regulated by TNF-α is consistent with data from an earlier study by Trautwein et al. (1992)in which a Cyp2d-like mRNA species was down-regulated by this cytokine in the C3H/HeJ mouse. Our finding that TNF-α suppressesCyp2d9 mRNA is also consistent with a recent study by Warren et al. (1999) in which it was noted that Cyp2d9 activity (testosterone 16α-hydroxytestostertone formation) is lower in TNF-α receptor knockout mice. In the same study, the effects of lipopolysaccharide on Cyp2b and 3a mRNAs were similar in knockout versus wild-type animals. This finding suggests that the effect of lipopolysaccharide on these enzymes occurs through a mechanism that is independent of TNF-α. The finding in the present study that Cyp2b10 and 3a11 mRNAs were unaffected by TNF-α supports this conclusion.

In summary, we have established a real-time quantitative RT-PCR technique to study Cyp mRNA expression in the mouse. This technique allows us to quantitatively measure a set of mouseCyp mRNAs and to study the effects of classic inducers and proinflammatory cytokines on Cyp mRNA expression in the mouse.

Acknowledgments

We thank Dr. Mark Cockett and Stephen Harnish (Wyeth-Ayerst Research, Princeton, NJ) for helpful discussions on TaqMan technology, Dr. Joann Scatina (Wyeth-Ayerst Research, Princeton, NJ), and Dr. Jun-Yan Hong (University of Medicine and Dentistry of New Jersey, Piscataway, NJ) for valuable comments on the manuscript.

Footnotes

  • Send reprint requests to: Dr. Jinmei Pan, Wyeth-Ayerst Research, Department of Drug Metabolism, CN 8000, Princeton, NJ 08543-8000. E-mail: panj{at}war.wyeth.com

  • Abbreviations used are::
    CYP
    cytochrome P450
    RT
    reverse transcription
    PCR
    polymerase chain reaction
    PB
    phenobarbital
    3-MC
    methylcholanthrene
    DEX
    dexamethasone
    Ct
    threshold cycle
    IL
    interleukin
    TNF-α
    tumor necrosis factor-α
    ΔRn
    delta normalized reporter fluorescence
    • Received December 15, 1999.
    • Accepted March 9, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics

References

  1. ↵
    1. Abdel-Razzak Z,
    2. Loyer P,
    3. Fautrel A,
    4. Gautier JC,
    5. Corcos L,
    6. Turlin B,
    7. Beaune P,
    8. Guillouzo A
    (1993) Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44:707–715.
    OpenUrlAbstract
  2. ↵
    1. Barker CW,
    2. Fagan JB,
    3. Sinclair JF
    (1992) Interleukin-1 beta suppresses the induction of P4501A1 and 1A2 mRNAs in isolated hepatocytes. J Biol Chem 267:8050–8055.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Bassler HA,
    2. Flood SJA,
    3. Livak KJ,
    4. Marmaro J,
    5. Knorr R,
    6. Batt CA
    (1995) Use of a fluorogenic probe in a PCR-based assay for the detection of Listeria monocytogenes. Appl Environ Microbiol 61:3724–3728.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Cantoni L,
    2. Carelli M,
    3. Ghezzi P,
    4. Delgado R,
    5. Faffioni R,
    6. Rizzardini M
    (1995) Mechanisms of interleukin-2-induced depression of hepatic cytochrome P-450 in mice. Eur J Pharmacol 292:257–263.
    OpenUrlPubMed
  5. ↵
    1. Chen JQ,
    2. Strom A,
    3. Gustafsson JA,
    4. Morgan ET
    (1995) Suppression of the constitutive expression of cytochrome P450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: Comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Mol Pharmacol 47:940–947.
    OpenUrlAbstract
  6. ↵
    1. Chen YL,
    2. Florentin I,
    3. Batt AM,
    4. Ferrari L,
    5. Giroud JP,
    6. Chauvelot-Moachon L
    (1992) Effect of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. Biochem Pharmacol 44:137–148.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Clark MA,
    2. Bing BA,
    3. Gottschall PE,
    4. Williams JF
    (1995) Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes. Biochem Pharmacol 6:97–104.
  8. ↵
    1. Corcos L
    (1992) PB and dexamethasone induce expression of cytochrome P-450 genes from subfamilies IIB, IIC, and IIIA in mouse liver. Drug Metab Dispos 20:797–801.
    OpenUrlAbstract
  9. ↵
    1. Damon M,
    2. Fautrel A,
    3. Guillouzo A,
    4. Corcos L
    (1996) Genetic analysis of the PB regulation of the cytochrome P450 2b9 and aldehyde dehydrogenase type 2 mRNAs in mouse liver. Biochem J 317:481–486.
  10. ↵
    1. Fukuda Y,
    2. Sassa S
    (1994) Suppression of cytochrome P4501A1 by interleukin-6 in human hepG2 hepatoma cells. Biochem Pharmacol 47:1187–1195.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Ghezzi P,
    2. Saccardo B,
    3. Villa P,
    4. Rossi V,
    5. Bianchi M,
    6. Dinarello CA
    (1986) Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infect Immunol 54:837–840.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Gibson UEM,
    2. Heid CA,
    3. Williams PM
    (1996) A novel method for real-time quantitative RT-PCR. Genome Res 6:995–1001.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Guillen MI,
    2. Donato MT,
    3. Jover R,
    4. Castell JV,
    5. Fabra R,
    6. Trullenque R,
    7. Gomez-Lechon MJ
    (1998) Oncostatin M down-regulates basal and induced cytochromes P450 in human hepatocytes. J Pharmacol Exp Ther 285:127–134.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Heid CA,
    2. Stevens J,
    3. Livak KJ,
    4. Williams PM
    (1996) Real-time quantitative PCR. Genome Res 6:986–994.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Kiyohara C,
    2. Mohri N,
    3. Hirohata T,
    4. Haraguchi K,
    5. Masuda Y,
    6. Nagayama J
    (1990) Aryl hydrocarbon hydroxylase activity levels in the hepatic microsomal fraction from MC- or TCDD-treated mice: A comparison between aromatic hydrocarbon responsive and non-responsive strains. Toxicol Lett 52:73–80.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Lee LG,
    2. Connell CR,
    3. Bloch W
    (1993) Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res 2:3761–3766.
    OpenUrl
  17. ↵
    1. Livak KJ,
    2. Flood SJA,
    3. Marmaro J,
    4. Giusti W,
    5. Deetz K
    (1995) Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 4:357–362.
    OpenUrlPubMed
  18. ↵
    1. Monshouwer M,
    2. Witkamp RF,
    3. Nujmeijer SM,
    4. Van Amsterdam JG,
    5. Van Miert AS
    (1996) Suppression of cytochrome P450- and UDP glucuronosyl transferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes. Toxicol Appl Pharmacol 137:237–244.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Morgan ET,
    2. Norman CA
    (1990) Pretranslational suppression of cytochrome P450h (IIC11) gene expression in rat liver after administration of interferon inducers. Drug Metab Dispos 18:649–653.
    OpenUrlAbstract
  20. ↵
    1. Morgan ET,
    2. Thomas KB,
    3. Swanson R,
    4. Vales T,
    5. Hwang J,
    6. Wright K
    (1994) Selective suppression of cytochrome P450 gene expression by interleukins 1 and 6 in rat liver. Biochim Biophys Acta 1219:475–483.
    OpenUrlPubMed
  21. ↵
    1. Nadin L,
    2. Butler AM,
    3. Farrell GC,
    4. Murray M
    (1995) Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor alpha. Gastroenterology 109:198–205.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Paton TE,
    2. Renton KW
    (1998) Cytokine-mediated down-regulation of CYP1A1 in Hepa1 cells. Biochem Pharmacol 55:1791–1796.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Renton KW,
    2. Knickle LC
    (1990) Regulation of hepatic cytochrome P-450 during infectious disease (Review). Can J Physiol Pharmacol 68:777–781.
    OpenUrlPubMed
  24. ↵
    1. Sakuma T,
    2. Ohtake M,
    3. Katsurayama Y,
    4. Jarukamjorn K,
    5. Nemoto N
    (1999) Induction of CYP1A2 by PB in the livers of aryl hydrocarbon-responsive and -nonresponsive mice. Drug Metab Dispos 27:379–384.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Shedlofsky SI,
    2. Israel BC,
    3. McClain CJ,
    4. Hill DB,
    5. Blouin RA
    (1994) Endotoxin administration to humans inhibits cytochrome P450-mediated drug metabolism. J Clin Invest 94:2209–2214.
  26. ↵
    1. Trautwein C,
    2. Ramadori G,
    3. Gerken G,
    4. Meyer zum Bödschenfelde K-H,
    5. Manns M
    (1992) Regulation of cytochrome P450 IID by acute phase mediators in C3H/HeJ mice. Biochem Biophys Res Commun 182:617–623.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Warren GW,
    2. Plolyac SM,
    3. Gary DS,
    4. Mattson MP,
    5. Blouin RA
    (1999) Hepatic cytochrome P450 expression in tumor necrosis factor-α receptor (p55/p75) knockout mice after endotoxin administration. J Pharmacol Exp Ther 288:945–950.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 28 (6)
Drug Metabolism and Disposition
Vol. 28, Issue 6
1 Jun 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Use of a Novel Real-Time Quantitative Reverse Transcription-Polymerase Chain Reaction Method to Study the Effects of Cytokines on Cytochrome P450 mRNA Expression in Mouse Liver
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Use of a Novel Real-Time Quantitative Reverse Transcription-Polymerase Chain Reaction Method to Study the Effects of Cytokines on Cytochrome P450 mRNA Expression in Mouse Liver

Jinmei Pan, Qian Xiang and Simon Ball
Drug Metabolism and Disposition June 1, 2000, 28 (6) 709-713;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Use of a Novel Real-Time Quantitative Reverse Transcription-Polymerase Chain Reaction Method to Study the Effects of Cytokines on Cytochrome P450 mRNA Expression in Mouse Liver

Jinmei Pan, Qian Xiang and Simon Ball
Drug Metabolism and Disposition June 1, 2000, 28 (6) 709-713;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human ADME Properties of Abrocitinib
  • MSCs Pharmacokinetics under liver diseases
  • In Vitro-In Vivo Extrapolation Using Empirical Scaling
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics